Staging of Alzheimer's disease-related neurofibrillary changes H Braak, EVA Braak Neurobiology of aging 16 (3), 271-278, 1995 | 2698 | 1995 |
A global view of hepatocellular carcinoma: trends, risk, prevention and management JD Yang, P Hainaut, GJ Gores, A Amadou, A Plymoth, LR Roberts Nature reviews Gastroenterology & hepatology 16 (10), 589-604, 2019 | 2644 | 2019 |
Design and endpoints of clinical trials in hepatocellular carcinoma JM Llovet, AM Di Bisceglie, J Bruix, BS Kramer, R Lencioni, AX Zhu, ... Journal of the National Cancer Institute 100 (10), 698-711, 2008 | 2002 | 2008 |
Mechanisms of hepatotoxicity H Jaeschke, GJ Gores, AI Cederbaum, JA Hinson, D Pessayre, ... Toxicological sciences 65 (2), 166-176, 2002 | 1738 | 2002 |
Cholangiocarcinoma N Razumilava, GJ Gores The Lancet 383 (9935), 2168-2179, 2014 | 1584 | 2014 |
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma J Bridgewater, PR Galle, SA Khan, JM Llovet, JW Park, T Patel, TM Pawlik, ... Journal of hepatology 60 (6), 1268-1289, 2014 | 1458 | 2014 |
Hepatocellular carcinoma: clinical frontiers and perspectives J Bruix, GJ Gores, V Mazzaferro Gut 63 (5), 844-855, 2014 | 1413 | 2014 |
Diagnosis and management of primary sclerosing cholangitis R Chapman, J Fevery, A Kalloo, DM Nagorney, KM Boberg, B Shneider, ... Hepatology 51 (2), 660-678, 2010 | 1403 | 2010 |
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis AE Feldstein, A Canbay, P Angulo, M Taniai, LJ Burgart, KD Lindor, ... Gastroenterology 125 (2), 437-443, 2003 | 1254 | 2003 |
Biliary tract cancers PC De Groen, GJ Gores, NF LaRusso, LL Gunderson, DM Nagorney New England Journal of Medicine 341 (18), 1368-1378, 1999 | 1200 | 1999 |
Pathogenesis, diagnosis, and management of cholangiocarcinoma S Rizvi, GJ Gores Gastroenterology 145 (6), 1215-1229, 2013 | 1188 | 2013 |
Cholangiocarcinoma 2020: the next horizon in mechanisms and management JM Banales, JJG Marin, A Lamarca, PM Rodrigues, SA Khan, LR Roberts, ... Nature reviews Gastroenterology & hepatology 17 (9), 557-588, 2020 | 1187 | 2020 |
Cholangiocarcinoma—evolving concepts and therapeutic strategies S Rizvi, SA Khan, CL Hallemeier, RK Kelley, GJ Gores Nature reviews Clinical oncology 15 (2), 95-111, 2018 | 1149 | 2018 |
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report PA Clavien, M Lesurtel, PMM Bossuyt, GJ Gores, B Langer, A Perrier The lancet oncology 13 (1), e11-e22, 2012 | 1098 | 2012 |
Free fatty acids promote hepatic lipotoxicity by stimulating TNF‐α expression via a lysosomal pathway AE Feldstein, NW Werneburg, A Canbay, ME Guicciardi, SF Bronk, ... Hepatology 40 (1), 185-194, 2004 | 1093 | 2004 |
mir-29 regulates Mcl-1 protein expression and apoptosis JL Mott, S Kobayashi, SF Bronk, GJ Gores Oncogene 26 (42), 6133-6140, 2007 | 1073 | 2007 |
Apoptosis and necrosis in the liver: a tale of two deaths? H Malhi, GJ Gores, JJ Lemasters Hepatology 43 (S1), S31-S44, 2006 | 894 | 2006 |
Ursodeoxycholic acid or clofibrate in the treatment of non‐alcohol‐induced steatohepatitis: a pilot study J Laurin, KD Lindor, JS Crippin, A Gossard, GJ Gores, J Ludwig, J Rakela, ... Hepatology 23 (6), 1464-1467, 1996 | 886 | 1996 |
Cathepsin B contributes to TNF-α–mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c ME Guicciardi, J Deussing, H Miyoshi, SF Bronk, PA Svingen, C Peters, ... The Journal of clinical investigation 106 (9), 1127-1137, 2000 | 883 | 2000 |
Lysosomes in cell death ME Guicciardi, M Leist, GJ Gores Oncogene 23 (16), 2881-2890, 2004 | 849 | 2004 |